A comprehensive view of novavax inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novavax's updated non-mRNA COVID-19 vaccine, Nuvaxovid XBB.1.5, now available in UK for 2024 vaccination season following receipt of wholesale license and green book update
Published: April 18, 2024 by Novavax Inc.
Novavax investor Shah Capital attempting to nominate two new independent board directors; Shah claims Novavax has been historically mismanaged
Published: April 15, 2024 by FiercePharma
Activist investor critical of Novavax for not using mRNA vaccination fears to boost sales of its COVID-19 vaccine; Shah Capital wants Novavax to market its protein-based vaccine directly to people concerned about safety of mRNA vaccines
Published: April 15, 2024 by Quartz
Shah Capital nominates two highly qualified independent director candidates for Novavax
Published: April 15, 2024 by GlobeNewswire
Australia: Novavax Receives Patent for 'Methods and compositions for inducing immune responses against clostridium difficile'
Published: April 05, 2024 by Australian Government

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count